Moreover, the Oslo-2 mAb did not bind to the HER2+ lung cancer cell line A549, or to HER2 negative prostate cancer, pancreatic cancer, lymphoma and leukemia cell lines (Figure 2). The gene discussed is ERBB2; the disease is prostate cancer.